EARNEST Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-113
| Closed | -$25.5K | – | 1052 |
|
2023
Q3 | $25.5K | Hold |
113
| – | – | ﹤0.01% | 451 |
|
2023
Q2 | $24.9K | Hold |
113
| – | – | ﹤0.01% | 444 |
|
2023
Q1 | $25.3K | Hold |
113
| – | – | ﹤0.01% | 432 |
|
2022
Q4 | $31.4K | Hold |
113
| – | – | ﹤0.01% | 396 |
|
2022
Q3 | $24K | Hold |
113
| – | – | ﹤0.01% | 421 |
|
2022
Q2 | $27K | Buy |
113
+100
| +769% | +$23.9K | ﹤0.01% | 407 |
|
2022
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 1050 |
|
2021
Q4 | $3K | Hold |
13
| – | – | ﹤0.01% | 986 |
|
2021
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 1059 |
|
2021
Q2 | $2K | Hold |
13
| – | – | ﹤0.01% | 1064 |
|
2021
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 1071 |
|
2020
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 1047 |
|
2020
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1120 |
|
2020
Q2 | $2K | Hold |
13
| – | – | ﹤0.01% | 975 |
|
2020
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 1061 |
|
2019
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1137 |
|
2019
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1126 |
|
2019
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1141 |
|
2019
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 1043 |
|
2018
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1137 |
|
2018
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 1052 |
|
2018
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1155 |
|
2018
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 1143 |
|
2017
Q4 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 1028 |
|
2017
Q1 | – | Sell |
-13
| Closed | -$2K | – | 873 |
|
2016
Q4 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 969 |
|